#Life Sciences
48 articles with this tag
OpenAI Unveils LifeSciBench
OpenAI's LifeSciBench is a new benchmark designed to test AI's real-world applicability in complex life science research, moving beyond basic question answering.
AI Agents in Healthcare Need Guardrails
AI agents are transforming healthcare, but leaders must ask critical questions about data, governance, and control before widespread adoption.
Snowflake Summit: AI Agents Enter Healthcare
Snowflake Summit 2026 highlights the move of AI agents from healthcare pilots to enterprise-wide, governed workflows, powered by new CoWork capabilities.
OpenAI Boosts AI for Drug Discovery
OpenAI's GPT-Rosalind receives major upgrades for life sciences, enhancing drug discovery and genomics with improved reasoning and workflow execution capabilities.
OpenAI Bets on AI for Biodefense
OpenAI launches Rosalind Biodefense, providing developers and government partners with access to its frontier AI for biodefense and pandemic preparedness.
AI Rewrites Pharma's Customer Playbook
AI is revolutionizing pharmaceutical customer engagement, moving beyond automation to hyper-personalization and cross-functional collaboration.
Databricks Unifies Clinical Data
Databricks' new open-source Site Feasibility Workbench brings clinical trial intelligence onto its Lakehouse, tackling data silos and improving auditability.
RWE for Med Affairs: Who's Using What?
Life sciences firms face a 'fluency gap' in generating real-world evidence (RWE). Databricks' Genie platform offers a solution, enabling rapid, natural-language querying of RWE.
Snowflake, Veeva Push AI Agents in Life Sciences
Snowflake and Veeva partner to bring agentic AI to life sciences, unifying data for faster insights and streamlined operations.
Databricks Aims to Speed Up Drug Trials
Databricks Genie aims to slash clinical trial delays by enabling natural language interrogation of complex data, speeding up treatment approvals and patient access.
OpenAI Leaders Discuss Building AI for Life Sciences
OpenAI's Joy Jiao and Yunyun Wang discuss how AI is transforming life sciences, enabling new discoveries and accelerating research workflows.
OpenAI Unveils GPT-Rosalind for Science
OpenAI launches GPT-Rosalind, a specialized AI model designed to accelerate life sciences research and drug discovery workflows.
TriNetX Speeds Drug Trials With Databricks
TriNetX uses Databricks' AI platform to significantly speed up drug development, cutting trial delays and improving research efficiency.
OpenAI Foundation Charts Its Course
OpenAI's Foundation outlines its multi-billion dollar mission to harness AI for humanity's benefit, focusing on health, economy, and safety.
TetraScience Unlocks Biopharma AI
TetraScience partners with Databricks to transform biopharma R&D by making lab data AI-ready, slashing development times and accelerating drug discovery.
Bayer Consumer Health Unifies Data with Databricks
Bayer Consumer Health leverages Databricks and Unity Catalog to create a unified, governed data platform, enabling global self-service analytics and eliminating data silos.
Agentic AI Life Sciences: Reshaping Enterprise Cognition
Salesforce Agentic AI Transforms Life Sciences with Agentforce
AI Agents That Unlock Regulated Life Sciences Workflows with LogicFlo AI
Medical information response times have shortened from one or two weeks to just days.
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
Superlab Suisse's new facility caters to a high concentration of life sciences research and entrepreneurship.
Kyron.bio Raises €5.5M to Advance Glycan-Engineered Drug Design
Biotech startup kyron.bio has raised €5.5 million in seed funding to develop its proprietary platform for precise glycan engineering, aiming to improve the s...
Kyron.bio Raises €5.5M to Advance Glycan-Engineered Drug Design
Biotech startup kyron.bio has raised €5.5 million in seed funding to develop its proprietary platform for precise glycan engineering, aiming to improve the s...
Biostate AI Raises $12M Series A to Power GenAI for Molecular Diagnostics
<p>Accel leads investment to scale RNA sequencing platform that predicts disease and treatment response using generative AI.</p>
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry
Cradle Accelerates Biotech with Generative AI and $73M
Converge Bio Raises $5.5M for Biotech LLMs
<p>$5.5 million in a seed round led by TLV Partners.</p><p>Converge Bio leverages open-source foundation models while developing proprietary processes.</p>
Converge Bio Raises $5.5M for Biotech LLMs
Converge Bio secured $5.5 million in seed funding, led by TLV Partners, to expand its platform that enhances the utility of biology-focused large language model...
Dante Genomics Launches Generative AI Powered Genomics Interpretation and Consultation
Dante Genomics, a leader in genomics and personalized medicine, has announced the integration of Generative AI into its flagship product, the Dante Labs Who...
Dante Genomics Launches Generative AI Powered Genomics Interpretation and Consultation
<p>Genomic data analysis using a proprietary platform based on artificial intelligence and machine learning.</p><p>Dante Labs Whole Genome platform with GenAI features will be available globally starting Q1 2025.</p>
Upstream Bio IPOs at $830M Valuation, Raises $255M, Advances Respiratory Treatments
Triomics Raises $15M to Automate Oncology Workflows with GenAI Platform
Nectin Therapeutics Secures $10 Million from GIBF to Propel Immunotherapy
IAG Capital Partners Leads $24M in Generative AI Startup for Drug Discovery, DeepCure
C2i Genomics Acquired for $95 Million by Veracyte
Accenture Ventures Backs QuantHealth, Clinical Trial Simulations
9xchange Partners with PhaseV on Causal Machine Learning Clinical Trial Optimization
PhaseV Nabs $15 Million Funding for ML Clinical Trial Optimization
Mana.bio Raises $14.5 Million Funding to Revolutionize AI Drug Delivery
Israeli AI biotechnology startup, Mana.bio, announced the raising of an additional $14.5 million for their Seed funding round.
Mana.bio Raises $14.5 Million Funding to Revolutionize AI Drug Delivery
Israeli AI biotechnology startup, Mana.bio, announced the raising of an additional $14.5 million for their Seed funding round.
Advancing Neurotoxicity Research with INTEGRA Biosciences Pipettes
INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as p...
Advancing Neurotoxicity Research with INTEGRA Biosciences Pipettes
INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as p...
ViAqua Therapeutics Secures $8.25 Million in Funding for Shellfish Disease Management
ViAqua Therapeutics, an Israel-based biotechnology startup specializing in aquaculture health, secured an $8.25 million funding round.
ViAqua Therapeutics Secures $8.25 Million in Funding for Shellfish Disease Management
ViAqua Therapeutics, an Israel-based biotechnology startup specializing in aquaculture health, secured an $8.25 million funding round.
US Venture Firm General Catalyst and Israel's Sheba Medical Center Boost Digital Health Tech
Mileutis Showcases Revolutionary Dairy Industry Solution at Stifel 2023 Jaws & Paws Conference
AI-Driven Patient Finder Analysis Launched by Verix on Tovana Platform
Immunai and Baylor College of Medicine Unveil BTG1 as New Molecular Target to Boost Cancer Immunotherapy
